Healthcare providers can assess injection technique, review site rotation practices, and consider whether alternative treatment options might be better tolerated
Disclosures Thorpe, Duchovny, and Kazi report no relevant conflicts of interest.
Skip the sugary soft drinks and opt for a tasty wellness drink instead
This treatment category has revolutionized the type 2 diabetes (T2D) space, achieving $20 billion in 2022 T2D sales, led by the success of Novo Nordisks Ozempic and Eli Lillys Mounjaro
This can still support your metabolism and fat burning, but the key to success is consistency
GLP-1 Supporting Supplements or Functional CPG: Biggest TAM growth opportunity...Supergut & Grns are very well positioned to capture new GLP-1 consumers